Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019

Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S103-S123
Open Access | Times Cited: 415

Showing 1-25 of 415 citing articles:

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 9, pp. 841-851
Open Access | Times Cited: 1418
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
Gary D. Lopaschuk, Subodh Verma
JACC Basic to Translational Science (2020) Vol. 5, Iss. 6, pp. 632-644
Open Access | Times Cited: 611
ACC/AHA Versus ESC/ESH on Hypertension Guidelines
George L. Bakris, Waleed Ali, Gianfranco Parati
Journal of the American College of Cardiology (2019) Vol. 73, Iss. 23, pp. 3018-3026
Closed Access | Times Cited: 258
Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association
Suzanne V. Arnold, Deepak L. Bhatt, Gregory W. Barsness, et al.
Circulation (2020) Vol. 141, Iss. 19
Open Access | Times Cited: 227
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
Chengxu Ma, Xiaoni Ma, Conghui Guan, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 219
Hypertension in pregnancy: Pathophysiology and treatment
Stephanie Braunthal, Andrei Brateanu
SAGE Open Medicine (2019) Vol. 7
Open Access | Times Cited: 218
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
Mee Kyoung Kim, Seung‐Hyun Ko, Bo‐Yeon Kim, et al.
Diabetes & Metabolism Journal (2019) Vol. 43, Iss. 4, pp. 398-398
Open Access | Times Cited: 203
An Effective Model of Diabetes Care and Education: Revising the AADE7 Self-Care Behaviors®

The Diabetes Educator (2020) Vol. 46, Iss. 2, pp. 139-160
Closed Access | Times Cited: 144
Role of aspirin in primary prevention of cardiovascular disease
Carlo Patrono, Colin Baigent
Nature Reviews Cardiology (2019) Vol. 16, Iss. 11, pp. 675-686
Open Access | Times Cited: 126
REDUCE-IT USA
Deepak L. Bhatt, Michael Miller, Eliot A. Brinton, et al.
Circulation (2019) Vol. 141, Iss. 5, pp. 367-375
Open Access | Times Cited: 120
GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists
José Luis Górriz, María José Soler, Juan F. Navarro‐González, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 947-947
Open Access | Times Cited: 118
Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease
Suzanne V. Arnold, James A. de Lemos, Robert S. Rosenson, et al.
Circulation (2019) Vol. 140, Iss. 7, pp. 618-620
Open Access | Times Cited: 109
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
Lawrence A. Leiter, Stephen C. Bain, Irene Hramiak, et al.
Cardiovascular Diabetology (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 106
Diabetes and Cardiovascular Disease: an Update
Rajaa Almourani, Bhavana Chinnakotla, Richa Patel, et al.
Current Diabetes Reports (2019) Vol. 19, Iss. 12
Closed Access | Times Cited: 93
Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis
Xiaoling Li, Nina C. Weber, Danny M. Cohn, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2419-2419
Open Access | Times Cited: 87
ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease
Cara Reiter–Brennan, Albert D. Osei, S.M. Iftekhar Uddin, et al.
Cleveland Clinic Journal of Medicine (2020) Vol. 87, Iss. 4, pp. 231-239
Open Access | Times Cited: 85
Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
Liyao Fu, Ying Zhou, Jiaxing Sun, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps
Jeffrey I. Mechanick, Michael E. Farkouh, Jonathan Newman, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 5, pp. 539-555
Open Access | Times Cited: 75
Lipoprotein (a) and diabetes mellitus
Claudia Lamina, Natalie C. Ward
Atherosclerosis (2022) Vol. 349, pp. 63-71
Open Access | Times Cited: 56
Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Adam J. Nelson, Emily C. O’Brien, Lisa A. Kaltenbach, et al.
JAMA Network Open (2022) Vol. 5, Iss. 2, pp. e2148030-e2148030
Open Access | Times Cited: 54
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2274-2274
Open Access | Times Cited: 54
Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events
Yang Yang, Nianchun Peng, Gang Chen, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 41
Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular Benefits
Subodh Verma
The American Journal of Cardiology (2019) Vol. 124, pp. S36-S44
Open Access | Times Cited: 74
Catalpol in Diabetes and its Complications: A Review of Pharmacology, Pharmacokinetics, and Safety
Ying Bai, Ruyuan Zhu, Yimiao Tian, et al.
Molecules (2019) Vol. 24, Iss. 18, pp. 3302-3302
Open Access | Times Cited: 64
Beneficial effects of pomegranate peel extract on plasma lipid profile, fatty acids levels and blood pressure in patients with diabetes mellitus type-2: A randomized, double-blind, placebo-controlled study
Milkica Grabež, Ranko Škrbić, Miloš P. Stojiljković, et al.
Journal of Functional Foods (2019) Vol. 64, pp. 103692-103692
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top